Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Календарь
Скринер
Новости
О нас

QDEL - QuidelOrtho Corporation Последние новости | Finranks

Home

/

QDEL

Q

QuidelOrtho Corporation (QDEL)

NMS – Цена в реальном времени. Валюта: USD

14.64

+0.65 (4.65%)

Рынок открыт: Aug 12, 2026, 2:49 PM EDT

13.72

-0.27 (-1.93%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China weakness and a softer respiratory testing environment.

QuidelOrtho Corporation (QDEL) Q2 2026 Earnings Call Transcript

QuidelOrtho Corporation (QDEL) Q2 2026 Earnings Call Transcript

QuidelOrtho Corporation (QDEL) Q2 2026 Earnings Call Transcript

QuidelOrtho Q2 Earnings Call Highlights

QuidelOrtho Q2 Earnings Call Highlights

QuidelOrtho NASDAQ: QDEL reported second-quarter revenue growth despite continued pressure from China and a softer respiratory testing environment, while lowering its full-year outlook and withdrawing free cash flow guidance.

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to earnings of $0.12 per share a year ago.

QuidelOrtho Reports Second Quarter 2026 Financial Results

QuidelOrtho Reports Second Quarter 2026 Financial Results

― Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ― ― Excluding China, total revenue grew 6% both as reported and in constant currency ― ― Company updates full-year 2026 financial guidance ― SAN DIEGO, Aug. 6, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a leading global provider of diagnostic solutions, today announced financial results for the second quarter ended June 28, 2026. Key Second Quarter 2026 Results: (all comparisons are to the prior year period) Total revenue was $631 million, an increase of 3% as reported and 2% in constant currency.

Implied Volatility Surging for QuidelOrtho Stock Options

Implied Volatility Surging for QuidelOrtho Stock Options

Investors need to pay close attention to QDEL stock based on the movements in the options market lately.

Видео

No Data

There is no data to display

Пресс-релизы

QuidelOrtho Reports Second Quarter 2026 Financial Results

QuidelOrtho Reports Second Quarter 2026 Financial Results

― Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ― ― Excluding China, total revenue grew 6% both as reported and in constant currency ― ― Company updates full-year 2026 financial guidance ― SAN DIEGO, Aug. 6, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a leading global provider of diagnostic solutions, today announced financial results for the second quarter ended June 28, 2026. Key Second Quarter 2026 Results: (all comparisons are to the prior year period) Total revenue was $631 million, an increase of 3% as reported and 2% in constant currency.